# US 2020/0390909 A1 · Drug fragment imaging agent conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0390909 A1
- Document ID: US20200390909A1
- Status: Published application
- Kind: A1
- Application number: 16/977,720
- Filed: 2019-03-06
- Published: 2020-12-17
- Earliest claimed: 2018-03-07
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Stefan Harmsen; Stephan Rogalla; Sanjiv Gambhir
- Web page: https://patentgrep.com/patent/US20200390909A1

## CPC

- A61K 49/0032: {Methine dyes, e.g. cyanine dyes}
- C09K 11/06: containing organic luminescent materials
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/5375: 1,4-Oxazines, e.g. morpholine
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- C09B 23/04: one >CH- group, e.g. cyanines, isocyanines, pseudocyanines
- A61B 1/00016: {using wireless means}
- A61B 1/041: {Capsule endoscopes for imaging}
- A61B 1/043: {for fluorescence imaging}
- A61B 1/2676: {Bronchoscopes}
- A61B 1/307: for the urinary organs, e.g. urethroscopes or cystoscopes
- A61B 1/313: for introducing through surgical openings, e.g. laparoscopes
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Functional dyes and methods of use are provided. The dyes are useful in a variety of medical applications including, but not limited to, diagnostic imaging and therapy, endoscopic applications for the detection of tumors and other abnormalities, particularly with oral administration of the dyes.

## Claims

### Claim 1

A functional dye of formula:
D-L-F
wherein:
D is a near infrared fluorescent dye;
L is an optional linker; and
F is a small molecule that targets a protein.

### Claim 2 (depends on 1)

The functional dye of claim 1, wherein the small molecule is a known drug, or a fragment of a known drug that targets a protein selected from the group consisting of (non)-receptor kinases, immune checkpoint proteins, G-protein-coupled receptors (GPCRs), influx transporters, efflux transporters, ion channels, human leukocyte antigens (HLA), proteases, caspases and nuclear receptors.

### Claim 3 (depends on 1, 2)

The functional dye of claim 1 or 2, wherein the protein is selected from a wild type, a splice variant,

### Claim 4 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein F comprises a small molecule kinase inhibitor or a small molecule kinase inhibitor fragment.

### Claim 5 (depends on 4)

The functional dye of claim 4, wherein the small molecule kinase inhibitor is selected from ceritinib and palbociclib.

### Claim 6 (depends on 4)

The functional dye of claim 4, wherein the small molecule kinase inhibitor fragment is selected from N-desmethyl imatinib, N-desmethyl bosutinib, N-desmethyl nintedanib, N-desmethyl ponatinib, N-desmethyl brigatinib, N-deshydroxyethyl dasatinib.

### Claim 7 (depends on 4)

The functional dye of claim 4, wherein the small molecule kinase inhibitor fragment comprises a fragment of nintedanib or lapatinib.

### Claim 8 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein F comprises a small molecule modulator of G-protein-coupled receptors (GPCRs) or a fragment of a small molecule modulator of G-protein-coupled receptors (GPCRs).

### Claim 9 (depends on 8)

The functional dye of claim 8, wherein the small molecule modulator of G-protein-coupled receptors (GPCRs) is selected from N-desmethyl sildenafil and N-desmethyl eszopiclone.

### Claim 10 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein F comprises a small molecule agonist of ion-channels.

### Claim 11 (depends on 10)

The functional dye of claim 10, wherein the small molecule agonist of ion-channels is procainamide.

### Claim 12 (depends on 1)

The functional dye of claim 1, wherein F comprises a small molecule of the following structure:

### Claim 13 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein F is selected from a fragment of formula (F1) and a fragment of formula (F2), wherein fragment (F1) is of the formula:
wherein:
X is selected from C(O)NR22, NR22, O and S, wherein R22 is selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl and substituted heteroaryl;
R20 is selected from substituted alkyl, substituted acyl, benzyl, substituted benzyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle;
R21 are each independently selected from alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
r is an integer from 0 to 4; and
fragment (F2) is of the formula
wherein:
X is selected from a N, CH and CR32, wherein R32 is selected from alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
T is a protein-targeting moiety comprising a fragment of a known drug that targets a protein selected from the group consisting of (non)-receptor kinases, immune checkpoint proteins, G-protein-coupled receptors (GPCRs), influx transporters, efflux transporters, ion channels, human leukocyte antigens (HLA), proteases, caspases and nuclear receptors from a small molecule kinase inhibitor or a fragment of a small molecule modulator of GPCRs;
R21′ are each independently selected from alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
r′ is an integer from 0 to 8.

### Claim 14 (depends on 13)

The functional dye of claim 13, wherein fragment (F1) is of the formula (F1A):
wherein:
q is an integer from 1 to 20;
R22 is selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl;
R16, R17, R18 and R19 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
X3 is selected from a heteroatom, a substituted heteroatom, CH2 and a substituted carbon atom.

### Claim 15 (depends on 14)

The functional dye of claim 14, wherein formula (F1A) is of the structure:

### Claim 16 (depends on 13)

The functional dye of claim 13, wherein fragment (F1) is of the formula (F1B):
wherein:
q is an integer from 1 to 20;
R22 is selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl;
R16, R17, R18 and R19 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
X3 is selected from a heteroatom, a substituted heteroatom, CH2 and a substituted carbon atom.

### Claim 17 (depends on 16)

The functional dye of claim 16, wherein formula (F1B) is of the structure:

### Claim 18 (depends on 13)

The functional dye of claim 13, wherein fragment (F1) is of the formula (F1C):
wherein:
s is an integer from 1 to 20; and
R23 to R31 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heterocycle, substituted heterocycle, heterocycle and substituted heterocycle.

### Claim 19 (depends on 18)

The functional dye of claim 18, wherein the formula (F1C) is of the structure:

### Claim 20 (depends on 13)

The functional dye of claim 13, wherein the formula (F1) is of the structure:

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The functional dye of any one of claims 1 to 20, wherein the near infrared fluorescent dye is a cyanine (Cy) dye.

### Claim 22 (depends on 21)

The functional dye of claim 21, wherein the cyanine dye is of the formula (A):
wherein:
R1 and R2 are each independently selected from H, alkyl, and (CH2)nR12, wherein n is an integer from 1 to 20 and R12 is selected from the group consisting of H, sulfonate, carboxylic acid, amine, quaternary ammonium cation, phosphate, ester, halogen, azide, cyano, alkyne, and heterocycle;
R3 and R4, are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R3 and R4 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl;
R7 and R8 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R7 and R8 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl;
R5, R6, R9 and R10 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
t is an integer from 0 to 1.

### Claim 23 (depends on 22)

The functional dye of claim 22, wherein the cyanine dye is substituted with at least one iodide.

### Claim 24 (depends on 22, 23)

The functional dye of claim 22 or 23, wherein the cyanine dye is substituted with at least one isotopic label.

### Claim 25 (depends on 24)

The functional dye of claim 24, wherein the isotopic label is selected from 2H, 120I, 123I, 124I, 125I, 131I, 209As, 210As, 211As, 35S, UC, 13C, 14C, 32P, 15N, 13N, 110In, 111In, 177Lu, 18F, 52Fe, 62Cu, 64Cu, 67Cu, 67Ga, 68Ga, 86Y, 90Y, 89Zr, 94mTc, 94Tc, 99mTc, 154Gd, 155Gd, 155Gd, 157Gd, 158Gd, 15O, 186Re, 188Re, 51M, 52mMn, 55Co, 72As, 75Br, 76Br, 82mRb and 83Sr.

### Claim 26 (depends on 22)

The functional dye of claim 22, wherein the cyanine dye is selected from:

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The functional dye of any one of claims 1 to 20, wherein the near infrared fluorescent dye is fluorescein or a derivative thereof.

### Claim 28 (depends on 27)

The functional dye of claim 27, wherein the fluorescein derivative is fluorescein isothiocyanate (FITC).

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The functional dye of any one of claims 1 to 20, wherein the near infrared fluorescent dye is rhodamine isothiocyanate (RITC).

### Claim 30 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein the functional dye is of the formula (A1):
wherein:
R1 and R2 are each independently selected from H, alkyl, and (CH2)nR12, wherein n is an integer from 1 to 20 and R12 is selected from the group consisting of H, sulfonate, carboxylic acid, amine, quaternary ammonium cation, phosphate, ester, halogen, azide, cyano, alkyne, and heterocycle;
R3 and R4, are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R3 and R4 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl;
R7 and R8 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R7 and R8 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl; and
R5, R6, R9 and R10 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
T is an integer from 0 to 1;
q is an integer from 1 to 20;
R22 is selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl;
R16, R17, R18 and R19 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
X3 is selected from a heteroatom, a substituted heteroatom, CH2 and a substituted carbon atom.

### Claim 31 (depends on 30)

The functional dye of claim 30, selected from the following structures:

### Claim 32 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein the functional dye is of the formula (A1a):
wherein:
R1 and R2 are each independently selected from H, alkyl, and (CH2)nR12, wherein n is an integer from 1 to 20 and R12 is selected from the group consisting of H, sulfonate, carboxylic acid, amine, quaternary ammonium cation, phosphate, ester, halogen, azide, cyano, alkyne, and heterocycle;
R3 and R4, are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R3 and R4 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl;
R7 and R8 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R7 and R8 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl; and
R5, R6, R9 and R10 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
T is an integer from 0 to 1;
q is an integer from 1 to 20;
R22 is selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, heteroaryl, substituted heteroaryl;
R16, R17, R18 and R19 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
X3 is selected from a heteroatom, a substituted heteroatom, CH2 and a substituted carbon atom.

### Claim 33 (depends on 32)

The functional dye of claim 32, of structure (10):

### Claim 34 (depends on 1, 2, 3)

The functional dye of any one of claims 1 to 3, wherein the functional dye is of the formula (A2):
wherein:
R1 and R2 are each independently selected from H, alkyl, and (CH2)nR12, wherein n is an integer from 1 to 20 and R12 is selected from the group consisting of H, sulfonate, carboxylic acid, amine, quaternary ammonium cation, phosphate, ester, halogen, azide, cyano, alkyne, and heterocycle;
R3 and R4, are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R3 and R4 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl;
R7 and R8 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
or R7 and R8 together with the carbon to which they are attached form a group selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle, substituted heterocycle, cycloalkyl and substituted cycloalkyl; and
R5, R6, R9 and R10 are each independently selected from H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, carboxy, phosphonate, carboxylate, cyano, hydroxyl, carboxyamide, sulfonamide, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
t is an integer from 0 to 1;
X is selected from a N, CH and CR32, wherein R32 is selected from alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;
T is a protein targeting moiety comprising a fragment of a known drug that targets a protein selected from the group consisting of (non)-receptor kinases, immune checkpoint proteins, G-protein-coupled receptors (GPCRs), influx transporters, efflux transporters, ion channels, human leukocyte antigens (HLA), proteases, caspases and nuclear receptors from a small molecule kinase inhibitor or a fragment of a small molecule modulator of GPCRs;
R21′ are each independently selected from alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, CF3, sulfonate, amino, substituted amino, amide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle; and
r′ is an integer from 0 to 8.

### Claim 35 (depends on 34)

The functional dye of claim 34, wherein T is a fragment of imatinib, bosutinib, nintedanib, ponatinib, brigatinib, dasatinib or palbociclib.

### Claim 36 (depends on 34)

The functional dye of claim 34, wherein T is a fragment of sildenafil or eszopiclone.

### Claim 37 (depends on 34)

The functional dye of claim 34, wherein T is selected from:

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

A pharmaceutical composition, comprising:
a functional dye of any one of claims 1-37; and
a pharmaceutically acceptable excipient.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

A pharmaceutical composition for use as an oral contrast agent, comprising:
a functional dye of any one of claims 1-37; and
a pharmaceutically acceptable excipient.

### Claim 40 (depends on 38, 39)

The pharmaceutical composition of claim 38 or 39, further comprising one or more agents selected from PEG and sodium bicarbonate.

### Claim 41 (depends on 40)

The pharmaceutical composition of claim 40, wherein the PEG is PEG3350.

### Claim 42 (depends on 38, 39, 40, 41)

A method of imaging a tumor, the method comprising:
administering a pharmaceutical composition according to any one of claims 38 to 41 to an individual;
detecting the presence of the functional dye;
wherein increased concentration of the dye is indicative of a lesion.

### Claim 43 (depends on 42)

The method of claim 42, wherein the functional dye is detected with a fluorescence endoscopic camera or a fluorescence bronchoscopic camera.

### Claim 44 (depends on 42)

The method of claim 42, wherein the functional dye is detected with a fluorescence capsule endoscopic camera, cystoscope or a laparoscope.

### Claim 45 (depends on 43, 44)

The method of claim 43 or 44 wherein the camera is a combined white light near-infrared (WL/NIRF) camera.

### Claim 46 (depends on 42, 43, 44, 45)

The method of any one of claims 42 to 45, wherein the lesion is a cancerous or precancerous lesion.

### Claim 47 (depends on 46)

The method of claim 46, wherein the lesion is found in one or more locations selected from the gastrointestinal tract, breast, brain, prostate, pancreas, skin, bladder, head, neck and thyroid.

### Claim 48 (depends on 27, 42)

The method of any one of claims 42 to 27, wherein administration of the functional dye is oral.

### Claim 49 (depends on 42, 43, 44, 45, 46, 47, 48)

The method of any one of claims 42 to 48, wherein detection of the dye is used to guide biopsy or surgical resection of the lesion.

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

A kit comprising:
a functional dye of any one of claims 1-37; and
a device for detecting the presence of the functional dye.

### Claim 51 (depends on 50)

The kit of claim 50, wherein the device for detection of the functional dye is selected from a capsule endoscope, a portable cytometer, a smartphone add on device and a wearable cytometer.

### Claim 52 (depends on 52)

The kit of claim 52, wherein the smartphone add on device is a combined NIRF/WL camera unit.
